z-logo
open-access-imgOpen Access
Myocardial Perfusion Imaging Using Ultrasound Contrast Agents
Author(s) -
Flordeliza S. Villanueva
Publication year - 2010
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2010.07.007
Subject(s) - ultrasound , food and drug administration , toolbox , contrast (vision) , medicine , perfusion , contrast enhanced ultrasound , radiology , medical physics , cardiology , computer science , pharmacology , artificial intelligence , programming language
Ultrasound contrast agents (UCAs) have been in the echocardiographic “toolbox” for many years. Two such agents (Definity [Lantheus Medical Imaging, North Billerica, Massachusetts] and Optison [GE Healthcare, Princeton, New Jersey]) are approved by the U.S. Food and Drug Administration (FDA) and

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom